@article{Брюханова_Литкін_Загайко_Бондарева_2021, title={THE EFFECT OF NMDA-RECEPTOR ANTAGONIST ON CARBOHYDRATE AND LIPID METABOLISM MARKERS IN SYRIAN GOLDEN HAMSTERS UNDER EXPERIMETAL INSULIN RESISTANCE SYNDROME AND DIABETES MELLITUS}, volume={78}, url={https://jpep.endocrinology.org.ua/index.php/1/article/view/740}, DOI={10.21856/j-PEP.2021.4.10}, abstractNote={<p><strong>Background. </strong>Diabetes mellitus (DM) is a significant cause of the premature mortality and nowadays a problem of this pathology effective treatment remains relevant. A number of studies have demonstrated the potential role of pancreatic NMDA receptors in glucose-stimulated insulin secretion. The purpose was to study the effect of NMDA-receptor antagonist memantine on carbohydrate and lipid metabolism in Syrian golden hamsters under experimental DM and insulin resistance syndrome (IR).</p> <p><strong>Materials and Methods.</strong> The study was conducted on Syrian golden male hamsters. IR syndrome and DM were modelled in animals. Animals were administered metformin, an NMDA receptor antagonist memantine, or combination of medicines for 2 weeks. Carbohydrate and lipid metabolism markers were determined in blood serum.</p> <p><strong>Results.</strong> It was found that significant hyperglycemia and hyperinsulinemia, hypertriacylglycerolemia, hypercholesterolemia and proatherogenic changes in the cholesterol content in lipoproteins were observed in animals under the conditions of experimental model pathologies comparison with the intact control group.</p> <p>Metformin administration corrected hyperglycemia in IR and DM, but normalization of the insulin level occurred only under IR. Memantine significantly reduced the HOMA-IR index relative to untreated animals (p˂0.01) under both pathologies. The combined administration of the medicines was accompanied by a correction of glycemia and insulinemia to the intact control level and a significant decrease in the HOMA-IR index statistically significant to the untreated group (p˂0.01).</p> <p>The metformin administration under IR leads to a correction of hypertriacylglycerolemia and LDL cholesterol (LDL-cholesterol), while under DM there was a decrease of lipid metabolism all markers. Memantine monotherapy under both pathologies leads to a significant decrease of LDL-cholesterol only, and under DM memantine exceeded the metformin effectiveness.</p> <p>The combined administration of the medicines under IR significantly normalized the total cholesterol, triacylglycerols and LDL-cholesterol content relative to untreated animals, and under DM these markers significantly exceeded similar markers in the metformin-treated group.</p> <p><strong>Conclusions.</strong> Memantine is promising for further study as a potential antidiabetic medicine.</p> <p><strong>Key</strong> <strong>words</strong><strong>:</strong> diabetes mellitus, insulin resistance, memantine, NMDA receptors, metformine.</p>}, number={4}, journal={Problems of Endocrine Pathology}, author={Брюханова, Тетяна and Литкін, Дмитро and Загайко, Андрій and Бондарева, Алла}, year={2021}, month={Dec.}, pages={72-79} }